Clinical trial
Donor Lymphocytes to Prevent Graft-Versus-Host Disease in Patients With Chronic…
NCT00004878 · Jonsson Comprehensive Cancer Center, Other · Withdrawn
Key facts
| NCT number | NCT00004878 |
|---|---|
| Title | Donor Lymphocytes to Prevent Graft-Versus-Host Disease in Patients With Chronic Myeloid Leukemia |
| Official title | A Study to Determine the Safety and Efficacy of Using CD8-High Density Microparticles (CD8-HDM) to Deplete CD8+ Cells From Donor Lymphocyte Infusion in Order to Reduce Graft-versus-Host Disease (GvHD) Without Compromising an Anti-Leukemia Effect in Patients With Chronic Myeloid Leukemia Given… |
| Lead sponsor | Jonsson Comprehensive Cancer Center, Other |
| Status | Withdrawn |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Graft Versus Host Disease, Leukemia |
| Intervention type | Biological, Drug, Procedure |
| Interventions | therapeutic allogeneic lymphocytes, cytarabine, fludarabine phosphate, idarubicin, methotrexate, tacrolimus, in vitro-treated peripheral blood stem cell transplantation, peripheral blood stem cell transplantation |
| Enrollment | 0 |
| First posted | Apr 28, 2004 |
| Last update posted | Jul 31, 2020 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: